SlideShare a Scribd company logo
1 of 37
Genomics 101 Murugu Manickam, MD  discloses  no significant financial interests or other relationships with commercial interests.  Presentation  will not  include discussion of commercial products or services and  will not  include unapproved or off-label usage of a commercial product or device. The following planning committee members have  no  significant financial interests or relationships with commercial interests to disclose, their educational unit  does not  have a financial interest or affiliation with an organization that may receive direct benefit from the subject of the proposed CME activity, and they  will not  be personally compensated for their role in the planning or execution of this proposed CME activity by an organization other than The Ohio State University:  Amy Ehrlich, MA  and Henry Zheng, PhD, MBA Murugu Manickam, MD Clinical Assistant Professor Division of Human Genetics
Genetics and Genomics  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Genes ,[object Object],[object Object],[object Object],[object Object]
Some Differences Travel Together ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
HAP-MAP Project ,[object Object],[object Object]
Single Nucleotide Polymorphism ,[object Object],[object Object],[object Object],A-C-T-A- G -C-T-A-G-C-T-A- C -G-T-G-A-C-A-A-C-G-T-G- A -C-A-T-A A-C-T-A- G -C-T-A-G-C-T-A- C -G-T-G-A-C-A-A-C-G-T-G- A -C-A-T-A A-C-T-A- T -C-T-A-G-C-T-A- A -G-T-G-A-C-A-A-C-G-T-G- G -C-A-T-A A-C-T-A- T -C-T-A-G-C-T-A- A -G-T-G-A-C-A-A-C-G-T-G- G -C-A-T-A
Genome Wide Association Studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Genome Wide Association Studies
Genome Wide Association Studies ,[object Object],[object Object],[object Object],[object Object]
 
Weaknesses of GWA Studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Copy Number Variant ,[object Object],[object Object]
Extra/Missing copies ,[object Object],[object Object],[object Object],[object Object]
Copy Number Variant ,[object Object],[object Object],[object Object]
Then and Now and Tomorrow Cost ,[object Object],[object Object],[object Object],[object Object],[object Object]
Then and Now and Tomorrow Time ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Then and Now and Tomorrow Comparison to Others ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Sequencing ,[object Object],[object Object],[object Object],[object Object]
Sequencing ,[object Object],[object Object],[object Object],[object Object]
Relative Risk/ Absolute Risk ,[object Object],[object Object],[object Object],[object Object]
Relative Risk/ Absolute Risk ,[object Object],[object Object],[object Object],[object Object]
Relative Risk/ Absolute Risk ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Relative Risk/ Absolute Risk ,[object Object],[object Object],[object Object],[object Object],[object Object]
Relative Risk ,[object Object],[object Object],RR <1: protective RR >1: risk R=1 no relationship
Relative Risk ,[object Object],But dependent on baseline risk (1.5%) RR= 1.5 Absolute risk- 2.25% RR= 2 Absolute risk- 3% RR= 5 Absolute risk- 7.5% ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Relative Risk ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],But dependent on baseline risk (7.5%) RR= 1.5 Absolute risk- 11.25% RR= 2 Absolute risk- 15% RR= 5 Absolute risk- 37.5%
Relative Risk ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Plus additive/multiplicative risk and protective factors that individually might be small but collectively have a large effect over time
Relative Risk ,[object Object],So a SNPs changes that increase risk could be offset by behavioral changes that decrease risk. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Comparison to Other Risk Stratification ,[object Object],[object Object],[object Object],[object Object],[object Object],Age RR 50-54 2 LDL >190 1.6 HDL <35 1.6 SBP <160 3 Diabetes 1.6 Smoker 1.6
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Comparison to Other Risk Stratification Subject to pharmaceutical and lifestyle interventions Conservatively a $100 billion industry
[object Object],[object Object],Comparison to Other Risk Stratification
Direct to Consumer Companies ,[object Object],[object Object]
Direct to Consumer Companies ,[object Object],[object Object],[object Object],[object Object],[object Object],* Many have a disclaimer that the information gained is not for medical use
Direct to Consumer Companies ,[object Object],[object Object],[object Object]
Preventative Health ,[object Object],[object Object],[object Object]
Do you feel comfortable talking to a patient if they bring in a report like this to you…
[object Object],[object Object]

More Related Content

Viewers also liked

Hypertension (BLOOD PRESSURE)
Hypertension (BLOOD PRESSURE)Hypertension (BLOOD PRESSURE)
Hypertension (BLOOD PRESSURE)Muhammad Arsal
 
Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension Toufiqur Rahman
 
Hypertension power point
Hypertension power pointHypertension power point
Hypertension power pointkreid204
 

Viewers also liked (7)

What are piles and its homeopathic treatment.
What are piles and its homeopathic treatment.What are piles and its homeopathic treatment.
What are piles and its homeopathic treatment.
 
Hypertension (BLOOD PRESSURE)
Hypertension (BLOOD PRESSURE)Hypertension (BLOOD PRESSURE)
Hypertension (BLOOD PRESSURE)
 
Rabies ppt
Rabies pptRabies ppt
Rabies ppt
 
Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension power point
Hypertension power pointHypertension power point
Hypertension power point
 
Pile foundation
Pile foundationPile foundation
Pile foundation
 

Similar to Genomics 101: Understanding Relative Risk and Absolute Risk

Construct precisephenotypesbigdatachallenge
Construct precisephenotypesbigdatachallengeConstruct precisephenotypesbigdatachallenge
Construct precisephenotypesbigdatachallengeAthula Herath
 
ConstructPrecisePhenotypesBigDataChallenge
ConstructPrecisePhenotypesBigDataChallengeConstructPrecisePhenotypesBigDataChallenge
ConstructPrecisePhenotypesBigDataChallengeAthula Herath
 
The Age of Personalized Medicine - Daniel A. Notterman, M.A., M.D.
The Age of Personalized Medicine - Daniel A. Notterman, M.A., M.D.The Age of Personalized Medicine - Daniel A. Notterman, M.A., M.D.
The Age of Personalized Medicine - Daniel A. Notterman, M.A., M.D.PennStateHersheyMarketing
 
Web cast cancer gene panels march 11 2015
Web cast cancer gene panels march 11 2015Web cast cancer gene panels march 11 2015
Web cast cancer gene panels march 11 2015Andreas Scherer
 
Cancer Gene Panels
Cancer Gene PanelsCancer Gene Panels
Cancer Gene PanelsGolden Helix
 
Deep learning-based cancer patient stratification
Deep learning-based cancer patient stratification Deep learning-based cancer patient stratification
Deep learning-based cancer patient stratification Altuna Akalin
 
Research Methodology 1
 Research Methodology 1 Research Methodology 1
Research Methodology 1Tamer Hifnawy
 
Big data biology for pythonistas: getting in on the genomics revolution
Big data biology for pythonistas: getting in on the genomics revolutionBig data biology for pythonistas: getting in on the genomics revolution
Big data biology for pythonistas: getting in on the genomics revolutionDarya Vanichkina
 
Genetic Disorders Fac 2007
Genetic Disorders Fac 2007Genetic Disorders Fac 2007
Genetic Disorders Fac 2007eifelr
 
Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...
Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...
Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...Cirdan
 
1- Why was the Tomasetti et al article so misinterpreted by th
1- Why was the Tomasetti et al article so misinterpreted by th1- Why was the Tomasetti et al article so misinterpreted by th
1- Why was the Tomasetti et al article so misinterpreted by thAgripinaBeaulieuyw
 
1- Why was the Tomasetti et al article so misinterpreted by th
1- Why was the Tomasetti et al article so misinterpreted by th1- Why was the Tomasetti et al article so misinterpreted by th
1- Why was the Tomasetti et al article so misinterpreted by thsachazerbelq9l
 
1- Why was the Tomasetti et al article so misinterpreted by th.docx
1- Why was the Tomasetti et al article so misinterpreted by th.docx1- Why was the Tomasetti et al article so misinterpreted by th.docx
1- Why was the Tomasetti et al article so misinterpreted by th.docxjeremylockett77
 
From reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene findingFrom reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene findingJoaquin Dopazo
 
Atul Butte's presentation for the FDA 5th Annual Scientific Computing Days
Atul Butte's presentation for the FDA 5th Annual Scientific Computing DaysAtul Butte's presentation for the FDA 5th Annual Scientific Computing Days
Atul Butte's presentation for the FDA 5th Annual Scientific Computing DaysUniversity of California, San Francisco
 

Similar to Genomics 101: Understanding Relative Risk and Absolute Risk (20)

2009 09 08 Wiltshire Ipit Seminar Slides
2009 09 08 Wiltshire Ipit Seminar Slides2009 09 08 Wiltshire Ipit Seminar Slides
2009 09 08 Wiltshire Ipit Seminar Slides
 
Construct precisephenotypesbigdatachallenge
Construct precisephenotypesbigdatachallengeConstruct precisephenotypesbigdatachallenge
Construct precisephenotypesbigdatachallenge
 
HINZ Education Workshop: Evidence Based Practice
HINZ Education Workshop: Evidence Based PracticeHINZ Education Workshop: Evidence Based Practice
HINZ Education Workshop: Evidence Based Practice
 
ConstructPrecisePhenotypesBigDataChallenge
ConstructPrecisePhenotypesBigDataChallengeConstructPrecisePhenotypesBigDataChallenge
ConstructPrecisePhenotypesBigDataChallenge
 
The Age of Personalized Medicine - Daniel A. Notterman, M.A., M.D.
The Age of Personalized Medicine - Daniel A. Notterman, M.A., M.D.The Age of Personalized Medicine - Daniel A. Notterman, M.A., M.D.
The Age of Personalized Medicine - Daniel A. Notterman, M.A., M.D.
 
Web cast cancer gene panels march 11 2015
Web cast cancer gene panels march 11 2015Web cast cancer gene panels march 11 2015
Web cast cancer gene panels march 11 2015
 
Cancer Gene Panels
Cancer Gene PanelsCancer Gene Panels
Cancer Gene Panels
 
Deep learning-based cancer patient stratification
Deep learning-based cancer patient stratification Deep learning-based cancer patient stratification
Deep learning-based cancer patient stratification
 
Research Methodology 1
 Research Methodology 1 Research Methodology 1
Research Methodology 1
 
Big data biology for pythonistas: getting in on the genomics revolution
Big data biology for pythonistas: getting in on the genomics revolutionBig data biology for pythonistas: getting in on the genomics revolution
Big data biology for pythonistas: getting in on the genomics revolution
 
Genetic Disorders Fac 2007
Genetic Disorders Fac 2007Genetic Disorders Fac 2007
Genetic Disorders Fac 2007
 
Shape aha 2005
Shape   aha 2005Shape   aha 2005
Shape aha 2005
 
Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...
Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...
Morphologomics - Challenges for Surgical Pathology in the Genomic Age by Dr. ...
 
Organ cloning
Organ cloningOrgan cloning
Organ cloning
 
Neharika genetics
Neharika geneticsNeharika genetics
Neharika genetics
 
1- Why was the Tomasetti et al article so misinterpreted by th
1- Why was the Tomasetti et al article so misinterpreted by th1- Why was the Tomasetti et al article so misinterpreted by th
1- Why was the Tomasetti et al article so misinterpreted by th
 
1- Why was the Tomasetti et al article so misinterpreted by th
1- Why was the Tomasetti et al article so misinterpreted by th1- Why was the Tomasetti et al article so misinterpreted by th
1- Why was the Tomasetti et al article so misinterpreted by th
 
1- Why was the Tomasetti et al article so misinterpreted by th.docx
1- Why was the Tomasetti et al article so misinterpreted by th.docx1- Why was the Tomasetti et al article so misinterpreted by th.docx
1- Why was the Tomasetti et al article so misinterpreted by th.docx
 
From reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene findingFrom reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene finding
 
Atul Butte's presentation for the FDA 5th Annual Scientific Computing Days
Atul Butte's presentation for the FDA 5th Annual Scientific Computing DaysAtul Butte's presentation for the FDA 5th Annual Scientific Computing Days
Atul Butte's presentation for the FDA 5th Annual Scientific Computing Days
 

Recently uploaded

COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 

Recently uploaded (20)

COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 

Genomics 101: Understanding Relative Risk and Absolute Risk

  • 1. Genomics 101 Murugu Manickam, MD discloses no significant financial interests or other relationships with commercial interests. Presentation will not include discussion of commercial products or services and will not include unapproved or off-label usage of a commercial product or device. The following planning committee members have no significant financial interests or relationships with commercial interests to disclose, their educational unit does not have a financial interest or affiliation with an organization that may receive direct benefit from the subject of the proposed CME activity, and they will not be personally compensated for their role in the planning or execution of this proposed CME activity by an organization other than The Ohio State University: Amy Ehrlich, MA and Henry Zheng, PhD, MBA Murugu Manickam, MD Clinical Assistant Professor Division of Human Genetics
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.  
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36. Do you feel comfortable talking to a patient if they bring in a report like this to you…
  • 37.